Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives

RSC Adv., 2018,8, 29714-29744

Muhammad Younas 1, Christophe Hano 2, Nathalie Giglioli-Guivarc'h 3, Bilal Haider Abbasi 1, 3, 2

1 QAU - Quaid-i-Azam University, Pakistan
2 LBLGC - Laboratoire de Biologie des Ligneux et des Grandes Cultures, Université d'Orléans, France
3 BBV EA 2106 - Biomolécules et biotechnologies végétales, Université de Tours, France


Breast cancer is one of the most commonly diagnosed cancers around the globe and accounts for a large proportion of fatalities in women. Despite the advancement in therapeutic and diagnostic procedures, breast cancer still represents a major challenge. Current anti-breast cancer approaches include surgical removal, radiotherapy, hormonal therapy and the use of various chemotherapeutic drugs. However, drug resistance, associated serious adverse effects, metastasis and recurrence complications still need to be resolved which demand safe and alternative strategies. In this scenario, phytochemicals have recently gained huge attention due to their safety profile and cost-effectiveness. These phytochemicals modulate various genes, gene products and signalling pathways, thereby inhibiting breast cancer cell proliferation, invasion, angiogenesis and metastasis and inducing apoptosis. Moreover, they also target breast cancer stem cells and overcome drug resistance problems in breast carcinomas. Phytochemicals as adjuvants with chemotherapeutic drugs have greatly enhanced their therapeutic efficacy. This review focuses on the recently recognized molecular mechanisms underlying breast cancer chemoprevention with the use of phytochemicals such as curcumin, resveratrol, silibinin, genistein, epigallocatechin gallate, secoisolariciresinol, thymoquinone, kaempferol, quercetin, parthenolide, sulforaphane, ginsenosides, naringenin, isoliquiritigenin, luteolin, benzyl isothiocyanate, α-mangostin, 3,3′-diindolylmethane, pterostilbene, vinca alkaloids and apigenin.


Breast cancer
Cell proliferation
breast carcinomas
Published by

RSC Advances